ANCA Antibodies: biomarker evidence

ANCA Antibodies appears in 1 entry of the OSMF biomarker atlas, covering Inflammatory Bowel Disease (Crohn's/UC). Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Inflammatory Bowel Disease (Crohn's/UC)

Where ANCA Antibodies is reported

Also listed as: ANCA

ConditionDirectionCompared againstAssociated symptomsSource
Inflammatory Bowel Disease (Crohn's/UC)↑ elevatedulcerative colitis patients vs non-UC controls and healthy controls—Pang et al. 2020

Frequently asked questions

In which conditions is ANCA Antibodies altered?

In the OSMF atlas ANCA Antibodies is reported in Inflammatory Bowel Disease (Crohn's/UC). It is elevated in 1 across 1 entries.

Is there a standard clinical test for ANCA Antibodies?

The atlas entries for ANCA Antibodies do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal ANCA Antibodies result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). ANCA Antibodies across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/anca-antibodies.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-03 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.